Clinical Trial Update: Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

View source ↗

Summary

A completed clinical trial investigating new serum markers for diagnosing hepatocellular carcinoma (liver cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Stanford University | Conditions: Liver Cancer | Status: COMPLETED